These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 29786562)

  • 1. Application of hepatocyte-like cells to enhance hepatic safety risk assessment in drug discovery.
    Williams DP
    Philos Trans R Soc Lond B Biol Sci; 2018 Jul; 373(1750):. PubMed ID: 29786562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of stem-cell-derived hepatic endoderm in human drug discovery.
    Medine CN; Greenhough S; Hay DC
    Biochem Soc Trans; 2010 Aug; 38(4):1033-6. PubMed ID: 20658999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Donor-Dependent and Other Nondefined Factors Have Greater Influence on the Hepatic Phenotype Than the Starting Cell Type in Induced Pluripotent Stem Cell Derived Hepatocyte-Like Cells.
    Heslop JA; Kia R; Pridgeon CS; Sison-Young RL; Liloglou T; Elmasry M; Fenwick SW; Mills JS; Kitteringham NR; Goldring CE; Park BK
    Stem Cells Transl Med; 2017 May; 6(5):1321-1331. PubMed ID: 28456008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A transcriptomic study suggesting human iPSC-derived hepatocytes potentially offer a better in vitro model of hepatotoxicity than most hepatoma cell lines.
    Gao X; Liu Y
    Cell Biol Toxicol; 2017 Aug; 33(4):407-421. PubMed ID: 28144825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmaceutical Research on Liver Diseases Using iPS Cell and Genome Editing Technologies].
    Takayama K
    Yakugaku Zasshi; 2019; 139(10):1219-1225. PubMed ID: 31582604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of spherical human liver microtissues for prediction of clinical drug-induced liver injury.
    Proctor WR; Foster AJ; Vogt J; Summers C; Middleton B; Pilling MA; Shienson D; Kijanska M; Ströbel S; Kelm JM; Morgan P; Messner S; Williams D
    Arch Toxicol; 2017 Aug; 91(8):2849-2863. PubMed ID: 28612260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human hepatocytes derived from pluripotent stem cells: a promising cell model for drug hepatotoxicity screening.
    Gómez-Lechón MJ; Tolosa L
    Arch Toxicol; 2016 Sep; 90(9):2049-2061. PubMed ID: 27325232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional, Functional, and Mechanistic Comparisons of Stem Cell-Derived Hepatocytes, HepaRG Cells, and Three-Dimensional Human Hepatocyte Spheroids as Predictive In Vitro Systems for Drug-Induced Liver Injury.
    Bell CC; Lauschke VM; Vorrink SU; Palmgren H; Duffin R; Andersson TB; Ingelman-Sundberg M
    Drug Metab Dispos; 2017 Apr; 45(4):419-429. PubMed ID: 28137721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of Drug-Induced Liver Injury in Micropatterned Co-cultures Containing iPSC-Derived Human Hepatocytes.
    Ware BR; Berger DR; Khetani SR
    Toxicol Sci; 2015 Jun; 145(2):252-62. PubMed ID: 25716675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional Maturation of Induced Pluripotent Stem Cell Hepatocytes in Extracellular Matrix-A Comparative Analysis of Bioartificial Liver Microenvironments.
    Wang B; Jakus AE; Baptista PM; Soker S; Soto-Gutierrez A; Abecassis MM; Shah RN; Wertheim JA
    Stem Cells Transl Med; 2016 Sep; 5(9):1257-67. PubMed ID: 27421950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The application of engineered liver tissues for novel drug discovery.
    Lin C; Ballinger KR; Khetani SR
    Expert Opin Drug Discov; 2015 May; 10(5):519-40. PubMed ID: 25840592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human induced pluripotent stem cell-derived hepatocytes for toxicology testing.
    Mann DA
    Expert Opin Drug Metab Toxicol; 2015 Jan; 11(1):1-5. PubMed ID: 25385341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of three-dimensional culture conditions to human embryonic stem cell-derived definitive endoderm cells enhances hepatocyte differentiation and functionality.
    Ramasamy TS; Yu JS; Selden C; Hodgson H; Cui W
    Tissue Eng Part A; 2013 Feb; 19(3-4):360-7. PubMed ID: 23003670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Competency of different cell models to predict human hepatotoxic drugs.
    Gómez-Lechón MJ; Tolosa L; Conde I; Donato MT
    Expert Opin Drug Metab Toxicol; 2014 Nov; 10(11):1553-68. PubMed ID: 25297626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three-dimensional cultured liver-on-a-Chip with mature hepatocyte-like cells derived from human pluripotent stem cells.
    Kamei KI; Yoshioka M; Terada S; Tokunaga Y; Chen Y
    Biomed Microdevices; 2019 Jul; 21(3):73. PubMed ID: 31304567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human-Induced Pluripotent Stem Cell-Derived Hepatocytes and their Culturing Methods to Maintain Liver Functions for Pharmacokinetics and Safety Evaluation of Pharmaceuticals.
    Inoue T; Iwazaki N; Araki T; Hitotsumachi H
    Curr Pharm Biotechnol; 2020; 21(9):773-779. PubMed ID: 32003687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feeder-free and serum-free production of hepatocytes, cholangiocytes, and their proliferating progenitors from human pluripotent stem cells: application to liver-specific functional and cytotoxic assays.
    Nakamura N; Saeki K; Mitsumoto M; Matsuyama S; Nishio M; Saeki K; Hasegawa M; Miyagawa Y; Ohkita H; Kiyokawa N; Toyoda M; Akutsu H; Umezawa A; Yuo A
    Cell Reprogram; 2012 Apr; 14(2):171-85. PubMed ID: 22384928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stem-cell derived hepatocyte-like cells for the assessment of drug-induced liver injury.
    Donato MT; Tolosa L
    Differentiation; 2019; 106():15-22. PubMed ID: 30844688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using Human Induced Pluripotent Stem Cell-derived Hepatocyte-like Cells for Drug Discovery.
    Liu JT; Lamprecht MP; Duncan SA
    J Vis Exp; 2018 May; (135):. PubMed ID: 29863663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatectomised patient sera promote hepatocyte differentiation of human-induced pluripotent stem cells.
    Xing Q; Luo Y; Gao Y; Zhang S; Zhu Z; Wang Y; Yuan Q; Shu G; Lou C; Wang J; Wang P; Du Z
    Dig Liver Dis; 2014 Aug; 46(8):731-7. PubMed ID: 24881854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.